Clear cell chondrosarcoma (CCCS) is a very rare malignant bone tumor that can behave clinically as a benign or low-grade malignant bone tumor. It was first reported as a clear cell variant of chondrosarcoma by Unni et al. in 1976. 1) CCCS has a strong predilection for the epiphysis or metaphysis of long bones, especially the proximal end of the femur and humerus. However, there are only three cases of CCCS in the diaphysis of long bones 2,3) and furthermore, this tumor has never been reported to affect the diaphysis of the tibia.
but relatively distinct sclerotic border was identified at the anterior and distal endosteal portions of the lesion. In contrast, the posterior endosteal portion of the lesion had an ill-defined margin with a slightly infiltrative pattern. There was no periosteal reaction evident ( Fig. 1A, B ). Given the location of the tumor and its radiologic features, we assumed it to be fibrous dysplasia and performed an incisional biopsy, which identified it as a CCCS.
To re-evaluate the tumor, we performed CT and gadoliniumenhanced MRI (the previous MRI had included only limited images).
CT showed an intramedullary lesion with permeative endosteal bone destruction but incomplete disruption of the cortex ( Fig. 2A, B ). MRI showed similar findings with enhancement and without any muscular involvement, except a small area of hemorrhagic necrosis, which was thought to be due to previous biopsy ( Fig. 2C , D, E).
Chest CT, abdominal US and PET-CT showed no local or distant metastasis.
We planned wide resection of the tumor and structural allogenic bone graft of the site. Using wide margins, we resected the tibia shaft including the tumor and transplanted a piece of structural allogenic bone the same length of the tibia in its place. There was no muscular involvement, so we were able to save the muscles of the fied hyaline cartilage and mildly atypical nuclei (Fig. 4) .
The patient has been disease-free for 7 months. Bony union is under process between allogenic bone and remaining tibia with 3 months of a long leg cast and a patella tendon bearing brace afterward.
Discussion
One of the subtypes of chondrosarcoma, CCCS, is a very rare malignant bone tumor that comprises approximately 2% of chondrosarcomas. 2, 4) A recent US study analyzed 2890 cases of chondrosarcoma, 13 of which were CCCS (0.4%). 5) In most cases, diagnosis can be made microscopically. Histopathologic findings are characteristic and diagnostic. The tumor cells have a centrally located, round nucleus surrounded by clear, abundant cytoplasm and a well-defined cytoplasmic border. Most CCCS lesions contain variable amounts of hyaline cartilage, calcification and osteoid production that can be seen in chondroblastomas. [1] [2] [3] On conventional radiographs, CCCS typically presents as a radiolucent lesion with a distinct sclerotic border. The degree of radiolucency can be affected by calcified chondroid or osseous components, which can be confusing to physicians. Cortical involvement is common, but extensive cortical destruction or expansion to soft tissue is unusual. Computed tomography can more reliably detect cortical involvement and calcification, especially in flat bone and vertebrae.
MRI is the most useful imaging modality for detecting expansion to soft tissue. However, all radiologic features are nonspecific. 1, 6, 7) While conventional chondrosarcoma usually arises in the metaphysis or diaphysis, CCCS has a strong predilection for the epiphysis and metaphysis of long bones. Very few cases have been reported with expansion to the diaphysis or arising from the diaphysis itself. 1, 2, 3) The most common site of CCCS is the proximal femur followed by the proximal humerus. 1,2,4,6) Some reports have described other unusual sites including the scapula, rib, phalanx, etc. 2, 6, 8) In our case, radiographs revealed a simple radiolucent lesion with slight endosteal erosion but no periosteal reaction in the middle of the tibia. We consider fibrous dysplasia or low-grade osteosarcoma initially based on these findings. In fact, CCCS in the proximal tibia has been reported in only a few cases and only three cases in the diaphysis of long bones. Bjornsson et al. 2) reported one case of CCCS which had occurred in the diaphysis of the femur among 32 cases of long bone CCCS, but they omitted radiologic findings of the case.
Memis et al. 3) reported two unusual CCCS cases. One was an expansile lytic lesion involving the proximal two-thirds of the humeral shaft, and the other was a lesion in the medial cortex of the femoral shaft, which showed a highly destructive pattern. All diagnoses could Many treatment modalities have been reported. 1, 2, 7, 8) Simple excision or intralesional curettage resulted in recurrence and metastasis in more than 80%; thus, wide excision with sufficient surgical margins is recommended, as in our case.
Conclusion
To our knowledge, this is the first report of CCCS in the tibia diaphysis. Due to the tendency of this tumor to affect the epiphysis, it was nearly impossible to diagnose CCCS prior to biopsy when the diaphysis showed a radiographically benign or low-grade malignant bony lesion. When a non-aggressive bone tumor of the diaphysis is diagnosed in a long bone, we must always approach diagnosis using the basic principles for these tumors and CCCS must not be excluded from the differential diagnoses.
